PHIGENIX Trademark

Trademark Overview

On Wednesday, August 4, 2021, a trademark application was filed for PHIGENIX with the United States Patent and Trademark Office. The USPTO has given the PHIGENIX trademark a serial number of 90865364. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 2, 2024. The PHIGENIX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Pharmaceutical research services
phigenix

General Information

Serial Number90865364
Word MarkPHIGENIX
Filing DateWednesday, August 4, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 7, 2022

Trademark Statements

Goods and ServicesPharmaceutical drug development services; Pharmaceutical research services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 29, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOT AVAILABLE
Party Type20 - Owner at Publication
Legal Entity Type01 - Individual
AddressAtlanta, GA 30318
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressAtlanta, GA 30318

Trademark Events

Event DateEvent Description
Tuesday, May 3, 2022ASSIGNED TO EXAMINER
Saturday, August 7, 2021NEW APPLICATION ENTERED
Wednesday, September 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 3, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 18, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 7, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 1, 2023SOU TEAS EXTENSION RECEIVED
Friday, February 3, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 2, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 1, 2023SOU EXTENSION 1 FILED
Wednesday, February 1, 2023SOU EXTENSION 1 GRANTED
Friday, August 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 1, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, August 2, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, August 2, 2023SOU EXTENSION 2 FILED
Wednesday, August 2, 2023SOU EXTENSION 2 GRANTED
Saturday, February 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, September 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, February 1, 2024SOU EXTENSION 3 FILED
Thursday, February 1, 2024SOU EXTENSION 3 GRANTED

Related Keywords

phigenix services pharmaceutical research development drug